Takeda Pharmaceutical Company Limited (TKPHF) Financial Statements
Takeda Pharmaceutical Company Limited (TKPHF) files with the U.S. Securities and Exchange Commission under CIK 0001395064. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- 4.58 trillion JPY
- Net Income
- 108.14 billion JPY
- Total Assets
- 14.25 trillion JPY
- Net Cash from Operations
- 1.06 trillion JPY
Fiscal year ended Mar 31, 2025. Latest periodic SEC filing: Jun 25, 2025. Source: SEC filings (EDGAR XBRL). Amounts in JPY.
Open the full financial statements for TKPHF in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History